Newsroom | 209705 results

LOS ANGELES--(BUSINESS WIRE)--City of Hope® CEO Robert Stone, who leads one of the largest and most advanced cancer research and treatment organizations in the United States, has been recognized as one of the most influential leaders by two top health care trade publications: Modern Healthcare and Becker’s Hospital Review. Stone was honored for expanding access to advanced cancer care nationwide, advancing breakthrough cancer research, and developing a national network of lifesaving clinical tr...

WEST DES MOINES, Iowa--(BUSINESS WIRE)--ITA Group, een wereldwijde leider op het gebied van engagementoplossingen, kondigt de strategische overname aan van twee bekroonde Europese evenementenbureaus: C2events, gevestigd in West Yorkshire, Engeland, en Daymakers, gevestigd in Utrecht, Nederland. Met ingang van 31 oktober 2025 breiden deze overnames de lokale aanwezigheid en evenementencapaciteiten van ITA Group in heel Europa significant uit. De dubbele overnames versterken de positie van ITA Gr...

CANONSBURG, Pa.--(BUSINESS WIRE)--MFA provided insights into the current employer-group Medicare Advantage market and assessed membership trends by carrier and state....

BOSTON--(BUSINESS WIRE)--Mainstay Healthcare Partners (“Mainstay”), a strategic advisory and investment firm serving healthcare services and health technology companies, today announced the formation of its Strategic Advisory Board, bringing together industry-leading operators, investors and executive advisors who embody Mainstay’s philosophy of trusted, long-term partnership grounded in real operating experience. The creation of this team of strategic advisors reinforces Mainstay’s approach of...

HELSINKI--(BUSINESS WIRE)--Onego Bio, ein Lebensmittelzutatenhersteller, der mithilfe präziser Fermentation* tierfreies Eiprotein produziert, hat heute die Einführung einer neuen Expertenreihe mit dem Titel „The Power of Trichoderma reesei: Building the Future with Fungi.“ Diese mehrteilige Initiative verdeutlicht das volle Potenzial von Trichoderma reesei, der mikrobiellen Plattform hinter Bioalbumen® von Onego, indem sie dessen wissenschaftliche Stärken, industrielle Skalierbarkeit und prakti...

HELSINKI--(BUSINESS WIRE)--Onego Bio, une entreprise spécialisée dans les ingrédients alimentaires et produisant des protéines d'œufs non animales par fermentation de précision*, a annoncé aujourd'hui le lancement d'une nouvelle série de conférences d'experts intitulée « La puissance de Trichoderma reesei : construire l'avenir avec les champignons. » Cette action en plusieurs volets révèle tout le potentiel de Trichoderma reesei, la plateforme microbienne à l’origine de Bioalbumen® d’Onego, en...

BOULDER, Colo.--(BUSINESS WIRE)--Enveda, a clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life’s chemistry, today announced that it has initiated two parallel Phase 2a clinical trials evaluating ENV-294, a first-in-class oral small molecule, for the treatment of moderate-to-severe Atopic Dermatitis (AD) and Asthma. "The initiation of these Phase 2a trials is a major step in our strategy to unlock the full potentia...

ANAHEIM, Calif.--(BUSINESS WIRE)--The 2025 IHI Forum has convened, bringing together health care leaders, clinicians, patient advocates, and QI professionals from around the world....

ONTARIO, Calif.--(BUSINESS WIRE)--Prime Healthcare is proud to announce that Sunny Bhatia, MD, MMM, FACHE, FACC, FSCAI was recognized by Modern Healthcare as one of the 100 Most Influential People in Healthcare of 2025. This prestigious recognition program acknowledges and honors individuals who are deemed by the Modern Healthcare newsroom to be the most influential figures in the industry in terms of leadership and impact. The national honor is considered one of the industry’s highest distinct...

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us” or “our”) today responded to the amended transaction terms of the proposed acquisition of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) by Alcon Inc. (“Alcon”) (NYSE: ALC). Broadwood, which owns 30.2% of STAAR’s outstanding common stock, continues to oppose the proposed sale of the Company to Alcon and issued the following statement: “STAAR spent months trying to conv...